Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 33

1.

Two-fold elevation of endogenous GDNF levels in mice improves motor coordination without causing side-effects.

Mätlik K, Võikar V, Vilenius C, Kulesskaya N, Andressoo JO.

Sci Rep. 2018 Aug 8;8(1):11861. doi: 10.1038/s41598-018-29988-1.

2.

Altered serum levels of glial cell line-derived neurotrophic factor in male chronic schizophrenia patients with tardive dyskinesia.

Ye F, Zhan Q, Xiao W, Sha W, Zhang X.

Int J Methods Psychiatr Res. 2018 Jun 14:e1727. doi: 10.1002/mpr.1727. [Epub ahead of print]

PMID:
29901253
3.

Effects of Environmental Enrichment on Nicotine Sensitization in Rats Neonatally Treated with Quinpirole: Analyses of Glial Cell Line-Derived Neurotrophic Factor and Implications towards Schizophrenia.

Brown RW, Schlitt MA, Owens AS, DePreter CC, Cummins ED, Kirby SL, Gill WD, Burgess KC.

Dev Neurosci. 2018;40(1):64-72. doi: 10.1159/000486391. Epub 2018 Feb 14.

4.

Serum nerve growth factor beta, brain- and glial-derived neurotrophic factor levels and psychopathology in unmedicated patients with schizophrenia.

Chu CS, Chu CL, Wu CC, Lu T.

J Chin Med Assoc. 2018 Jun;81(6):577-581. doi: 10.1016/j.jcma.2017.11.010. Epub 2018 Feb 1.

5.

Impaired Latent Inhibition in GDNF-Deficient Mice Exposed to Chronic Stress.

Buhusi M, Brown CK, Buhusi CV.

Front Behav Neurosci. 2017 Oct 10;11:177. doi: 10.3389/fnbeh.2017.00177. eCollection 2017.

6.

Glial Cell Line-Derived Neurotrophic Factor (GDNF) serum level in women with schizophrenia and depression, correlation with clinical and metabolic parameters.

Skibinska M, Kapelski P, Pawlak J, Rajewska-Rager A, Dmitrzak-Weglarz M, Szczepankiewicz A, Czerski P, Twarowska-Hauser J.

Psychiatry Res. 2017 Oct;256:396-402. doi: 10.1016/j.psychres.2017.07.014. Epub 2017 Jul 6.

PMID:
28689143
7.

Association between serum levels of glutamate and neurotrophic factors and response to clozapine treatment.

Krivoy A, Hochman E, Sendt KV, Hollander S, Vilner Y, Selakovic M, Weizman A, Taler M.

Schizophr Res. 2018 Feb;192:226-231. doi: 10.1016/j.schres.2017.05.040. Epub 2017 Jun 7.

PMID:
28599751
8.

Cognitive impairment in first-episode drug-naïve patients with schizophrenia: Relationships with serum concentrations of brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor.

Xiao W, Ye F, Liu C, Tang X, Li J, Dong H, Sha W, Zhang X.

Prog Neuropsychopharmacol Biol Psychiatry. 2017 Jun 2;76:163-168. doi: 10.1016/j.pnpbp.2017.03.013. Epub 2017 Mar 22.

PMID:
28342945
9.

An analysis of the rewarding and aversive associative properties of nicotine in the neonatal quinpirole model: Effects on glial cell line-derived neurotrophic factor (GDNF).

Brown RW, Kirby SL, Denton AR, Dose JM, Cummins ED, Drew Gill W, Burgess KC.

Schizophr Res. 2018 Apr;194:107-114. doi: 10.1016/j.schres.2017.03.024. Epub 2017 Mar 14.

PMID:
28314679
10.

Atypical antipsychotic treatment increases glial cell line-derived neurotrophic factor serum levels in drug-free schizophrenic patients along with improvement of psychotic symptoms and therapeutic effects.

Xiao W, Ye F, Ma L, Tang X, Li J, Dong H, Sha W, Zhang X.

Psychiatry Res. 2016 Dec 30;246:617-622. doi: 10.1016/j.psychres.2016.11.001. Epub 2016 Nov 3.

PMID:
27836239
11.

hVGAT-mCherry: A novel molecular tool for analysis of GABAergic neurons derived from human pluripotent stem cells.

DeRosa BA, Belle KC, Thomas BJ, Cukier HN, Pericak-Vance MA, Vance JM, Dykxhoorn DM.

Mol Cell Neurosci. 2015 Sep;68:244-57. doi: 10.1016/j.mcn.2015.08.007. Epub 2015 Aug 16.

12.

Vitamin D regulates tyrosine hydroxylase expression: N-cadherin a possible mediator.

Cui X, Pertile R, Liu P, Eyles DW.

Neuroscience. 2015 Sep 24;304:90-100. doi: 10.1016/j.neuroscience.2015.07.048. Epub 2015 Jul 23.

PMID:
26210580
14.

Angiogenesis in the pathophysiology of schizophrenia - a comprehensive review and a conceptual hypothesis.

Lopes R, Soares R, Coelho R, Figueiredo-Braga M.

Life Sci. 2015 May 1;128:79-93. doi: 10.1016/j.lfs.2015.02.010. Epub 2015 Mar 2. Review. No abstract available.

PMID:
25744402
15.

Diverse glial cell line-derived neurotrophic factor (GDNF) support between mania and schizophrenia: a comparative study in four major psychiatric disorders.

Tunca Z, Kıvırcık Akdede B, Özerdem A, Alkın T, Polat S, Ceylan D, Bayın M, Cengizçetin Kocuk N, Şimşek S, Resmi H, Akan P.

Eur Psychiatry. 2015 Feb;30(2):198-204. doi: 10.1016/j.eurpsy.2014.11.003. Epub 2014 Dec 24.

PMID:
25543333
16.

Use of candidate gene markers to guide antipsychotic dosage adjustment.

Hettige NC, Zai C, Hazra M, Borlido C, Kennedy JL, Strauss J, Le Foll B, Wong A, Remington G, De Luca V.

Prog Neuropsychopharmacol Biol Psychiatry. 2014 Oct 3;54:315-20. doi: 10.1016/j.pnpbp.2014.07.001. Epub 2014 Jul 9.

PMID:
25016278
17.

Association between serum levels of glial cell-line derived neurotrophic factor and attention deficits in schizophrenia.

Niitsu T, Shirayama Y, Matsuzawa D, Shimizu E, Hashimoto K, Iyo M.

Neurosci Lett. 2014 Jul 11;575:37-41. doi: 10.1016/j.neulet.2014.05.034. Epub 2014 May 24.

PMID:
24861509
18.

Long-chain polyunsaturated fatty acids (LCPUFA) from genesis to senescence: the influence of LCPUFA on neural development, aging, and neurodegeneration.

Janssen CI, Kiliaan AJ.

Prog Lipid Res. 2014 Jan;53:1-17. doi: 10.1016/j.plipres.2013.10.002. Epub 2013 Oct 24. Review.

PMID:
24334113
19.

Glial cell line-derived neurotrophic factor (GDNF) as a novel candidate gene of anxiety.

Kotyuk E, Keszler G, Nemeth N, Ronai Z, Sasvari-Szekely M, Szekely A.

PLoS One. 2013 Dec 6;8(12):e80613. doi: 10.1371/journal.pone.0080613. eCollection 2013.

20.

Administration of mesenchymal stem cells and ziprasidone enhanced amelioration of ischemic brain damage in rats.

Kaengkan P, Baek SE, Kim JY, Kam KY, Do BR, Lee ES, Kang SG.

Mol Cells. 2013 Dec;36(6):534-41. doi: 10.1007/s10059-013-0235-2. Epub 2013 Nov 28.

Supplemental Content

Loading ...
Support Center